MINAPHARM Pharmaceuticals reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was EGP 972.24 million compared to EGP 799.25 million a year ago. Net income was EGP 49.93 million compared to EGP 130.51 million a year ago.

Basic earnings per share from continuing operations was EGP 3.86 compared to EGP 10.24 a year ago.